ACT-AD is a coalition of committed national organizations seeking to accelerate the development of potential cures and treatments to slow, halt or reverse the progression of Alzheimer’s disease through research.

Find Out More

This is where you can find out the latest in news from the coalition. To join ACT-AD, click here.

Find Out More
  • Activities

    On March 15, the Accelerate Cure/Treatments for Alzheimer’s Disease (ACT-AD) Coalition hosted a one-hour webinar on symptomatic treatment in Alzheimer’s disease. During the program, leading experts shared their perspectives on the burden of Alzheimer’s disease symptoms on patients and their families, highlighted advances in neurobiology that relate to Alzheimer’s disease symptoms, and updated participants on recent clinical development activities to improve the treatment of Alzheimer’s disease behavioral and psychiatric symptoms. (Learn more)

  • Take Action

    Today Alzheimer's disease, or AD, is a fatal diagnosis with death preceded by a slow, painful decline and loss of quality of life. The ACT-AD Coalition believes we have the ability to vastly improve the outlook for people with AD and thier caregivers in the next decade and we are committed to working with a diverse group of stakeholders to Accelerate a Cure and Treatments for Alzheimer's Disease. (More Info)

  • Latest News

    The ACT-AD Coalition has sent a letter to the chairmen and ranking members of the U.S. Senate's and House of Representatives' Appropriations Subcommittees on Agriculture, Rural Development, Food and Drug Administration, and Related Agencies requesting they provide the U.S. Food and Drug Administration (FDA) with $2.8 billion in budget authority appropriations in Fiscal Year 2018. Learn more here.